🔗 Share this article

A shadow market for unlicensed slimming drugs is propelled by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Investigational Drug Acquiring Traction Online

The experimental drug, which is still in research studies, is being promoted by online personalities for its supposed weight-reducing effects. Viewers are urged to message these profiles privately for supplier links, while also obtaining promotional offers.

Thriving Commerce on Social Networks

Additionally, a flourishing trade exists on Telegram, where communities with thousands of members share “before and after” images, injection guides and assertions of next-day UK delivery. Sellers market the drug there before directing buyers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist patients lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Healthcare Professionals Voice Concerns

However, physicians and chemists have warned that the distribution of what remains an unlicensed drug in the UK is a cause for concern and could lead to individuals administering products of unknown origin.

Some experts stated the popularity for retatrutide could be connected to the rising cost of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unapproved medication that cannot be marketed or distributed for human use under the British medical regulations.

Some content creators try to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still violate medicines, advertising, and consumer laws, risking fines, legal action or imprisonment.

Platform Response and Material Removal

According to the social media company, the platform has removed problematic material and prohibited associated keywords and query recommendations. The organization stated it was committed to maintaining the service secure and investing in enhancing compliance measures.

Online Trading Operations

Research also discovered communities with up to 9,000 members marketing retatrutide using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately brings up channels with numerous of users, populated with images of weight loss, glowing testimonials and step-by-step instructions for preparing or administering at home.

After minutes of entering one community, a seller posted contact information, where most purchases take place. The seller provided an instruction manual and guaranteed shipping within two days. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one inquired about weight, medical conditions or previous experience.

Product Details and Pricing

Within these communities, posts show black plastic parcels with Royal Mail stickers, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at residence with sterile water, or pre-filled injectors usually sold at 160 pounds for 20 milligrams. When asked how long a injector should last, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for the messaging service stated it actively moderated dangerous content on its service including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are injecting materials they can’t verify. Although the science behind retatrutide is valid, these online versions may not contain what they advertise,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in demand to recent price rises for approved weight-loss medications such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake injections are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was clean,” she explained.

Her staff has previously seen patients injured by self-injection from unverified suppliers. “We understand the frustration, but buying from Telegram or communication platforms is gambling with your health,” stated the doctor. “These substances could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any government authority globally. “Consequently at this point no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a company experimental substance not yet authorized … may expose patients to possibly significant health risks”.